Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,400 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Endocrine Connections, 2022100 YEARS OF VITAMIN D: Combined hormonal contraceptives and vitamin D metabolism in adolescent girls
Öberg J., Jorde R., Figenschau Y. et al.
Olink Target 96
Frontiers in Cardiovascular Medicine, 2022Inhibition of IL17A Using an Affibody Molecule Attenuates Inflammation in ApoE-Deficient Mice
Kumawat A., Zegeye M., Paramel G. et al.
Olink Target 96 Mouse
International Journal of Molecular Sciences, 2022COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19
Costanzo M., Caterino M., Fedele R. et al.
Brain, 2022Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity
Ruck T., Barman S., Schulte-Mecklenbeck A. et al.
Olink Explore 3072/384
Journal of Clinical Medicine, 2022Proteomics-Based Serum Alterations of the Human Protein Expression after Out-of-Hospital Cardiac Arrest: Pilot Study for Prognostication of Survivors vs. Non-Survivors at Day 1 after Return of Spontaneous Circulation (ROSC)
Hinkelbein J., Kolaparambil Varghese Johnson L., Kiselev N. et al.
Journal of Thrombosis and Haemostasis, 2022Thrombosis pathways in COVID‐19 vs. influenza‐associated ARDS: A targeted proteomics approach
Rademaker E., Doorduijn D., Kusadasi N. et al.
PLOS ONE, 2022Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus–A randomized, placebo-controlled cross-over study
Suhrs H., Nilsson M., Bové K. et al.
Scientific Reports, 2022The role of caspase-1, caspase-4 and NLRP3 in regulating the host cell response evoked by uropathogenic Escherichia coli
Lindblad A., Johansson C., Persson K. et al.
Cell Reports Medicine, 2022Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma
Nahi H., Chrobok M., Meinke S. et al.
International Journal of Molecular Sciences, 2022Pleiotropic, Unique and Shared Responses Elicited by IL-6 Family Cytokines in Human Vascular Endothelial Cells
Lindkvist M., Zegeye M., Grenegård M. et al.
Immunity, 2022Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease
Vijayakumar B., Boustani K., Ogger P. et al.
Pulmonary Circulation, 2022Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension
Arvidsson M., Ahmed A., Säleby J. et al.
Cell, 2022Multiple early factors anticipate post-acute COVID-19 sequelae
Su Y., Yuan D., Chen D. et al.
Atherosclerosis, 2022Soluble CD40 receptor is a biomarker of the burden of carotid artery atherosclerosis in subjects at high cardiovascular risk
Leonetti S., Tricò D., Nesti L. et al.
Frontiers in Immunology, 2022Short Chain Fatty Acids Taken at Time of Thrombectomy in Acute Ischemic Stroke Patients Are Independent of Stroke Severity But Associated With Inflammatory Markers and Worse Symptoms at Discharge
Henry N., Frank J., McLouth C. et al.
Rheumatology, 2022Clinical features and immune-related protein patterns of anti-MDA5 positive clinically amyopathic dermatomyositis Dutch patients
Hensgens M., Delemarre E., Drylewicz J. et al.
Biomedicines, 2022Recent Developments in Clinical Plasma Proteomics—Applied to Cardiovascular Research
Palstrøm N., Matthiesen R., Rasmussen L. et al.
Clinical Cardiology, 2022Proteomic differences among patients with heart failure taking furosemide or torsemide
Cooper L., Bruce S., Psotka M. et al.
International Journal of Molecular Sciences, 2022IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis
Wang X., Kaiser H., Kvist-Hansen A. et al.
Cell Reports Medicine, 2022Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study
Wesolowska-Andersen A., Brorsson C., Bizzotto R. et al.
3478 publications
Items per page
701-720 of 3478 publications